Vendor, Austin, TX
Asuragen Incorporated
UEI E8M9NXN4X4Y7, CAGE 4GGP6
1 award and $246,475 obligated between April 26, 2024 and April 17, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | $246,475 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W81K0022P0237Purchase Order, April 26, 2024, Not Competed Under SAP, 1 offers | W40M MRC0 WestDepartment of the Army | Quantidex QPCR BCR Abl Is Kit - Exercise the FY25 Option Year.NAICS 325413, PSC 6515 | $246,475 |
- Places of performance
- Texas
- Product and service codes
- 6515 Medical and Surgical Instruments, Equipment, and Supplies
- Transactions
- 7 across 1 awards